Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Vincent Ribrag, Serge Koscielny, Jacques Bosq, Thibaut Leguay, Olivier Casasnovas, Luc-Mathieu Fornecker, Christian Recher, Hervé Ghesquieres, Franck Morschhauser, Stéphane Girault, Steven Le Gouill, Mario Ojeda-Uribe, Clara Mariette, Jerome Cornillon, Guillaume Cartron, Veronique Verge, Catherine Chassagne-Clément, Hervé Dombret, Bertrand Coiffier, Thierry Lamy, Hervé Tilly, Gilles Salles

Open source

DOI: 10.1016/s0140-6736(15)01317-3
Published: 2016-06
Container: The Lancet
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-15-01317-3,
  title = {Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial},
  author = {Vincent Ribrag and Serge Koscielny and Jacques Bosq and Thibaut Leguay and Olivier Casasnovas and Luc-Mathieu Fornecker and Christian Recher and Hervé Ghesquieres and Franck Morschhauser and Stéphane Girault and Steven Le Gouill and Mario Ojeda-Uribe and Clara Mariette and Jerome Cornillon and Guillaume Cartron and Veronique Verge and Catherine Chassagne-Clément and Hervé Dombret and Bertrand Coiffier and Thierry Lamy and Hervé Tilly and Gilles Salles},
  year = {2016},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(15)01317-3},
  url = {https://doi.org/10.1016/s0140-6736(15)01317-3}
}

RIS

TY  - JOUR
TI  - Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial
AU  - Vincent Ribrag
AU  - Serge Koscielny
AU  - Jacques Bosq
AU  - Thibaut Leguay
AU  - Olivier Casasnovas
AU  - Luc-Mathieu Fornecker
AU  - Christian Recher
AU  - Hervé Ghesquieres
AU  - Franck Morschhauser
AU  - Stéphane Girault
AU  - Steven Le Gouill
AU  - Mario Ojeda-Uribe
AU  - Clara Mariette
AU  - Jerome Cornillon
AU  - Guillaume Cartron
AU  - Veronique Verge
AU  - Catherine Chassagne-Clément
AU  - Hervé Dombret
AU  - Bertrand Coiffier
AU  - Thierry Lamy
AU  - Hervé Tilly
AU  - Gilles Salles
PY  - 2016
JO  - The Lancet
DO  - 10.1016/s0140-6736(15)01317-3
UR  - https://doi.org/10.1016/s0140-6736(15)01317-3
ER  -

APA

Ribrag, V., Koscielny, S., Bosq, J., Leguay, T., Casasnovas, O., Fornecker, L., Recher, C., Ghesquieres, H., Morschhauser, F., Girault, S., Gouill, S. L., Ojeda-Uribe, M., Mariette, C., Cornillon, J., Cartron, G., Verge, V., Chassagne-Clément, C., Dombret, H., Coiffier, B., Lamy, T., Tilly, H., & Salles, G. (2016). Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial. The Lancet. https://doi.org/10.1016/s0140-6736(15)01317-3

Source records

crossref · retrieved 2026-09-25T20:30:59.638Z